139 related articles for article (PubMed ID: 11668978)
1. U.S., Switzerland oppose developing-country proposal on access to medicines.
James JS
AIDS Treat News; 2001 Sep; (371):5. PubMed ID: 11668978
[No Abstract] [Full Text] [Related]
2. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
3. Access to essential drugs.
Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517
[No Abstract] [Full Text] [Related]
4. Access to AIDS medicines stumbles on trade rules.
Wise J
Bull World Health Organ; 2006 May; 84(5):342-4. PubMed ID: 16710536
[No Abstract] [Full Text] [Related]
5. WTO accepts rules limiting medicine exports to poor countries.
James JS
AIDS Treat News; 2003 Sep; (394):2-6. PubMed ID: 14669728
[TBL] [Abstract][Full Text] [Related]
6. The morally uncomfortable global drug gap.
Cohen-Kohler JC
Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
[TBL] [Abstract][Full Text] [Related]
7. India changes patent law to meet WTO treaty, making new medicines less available to most citizens, other countries.
James JS
AIDS Treat News; 2004; (407-408):6-7. PubMed ID: 15717384
[TBL] [Abstract][Full Text] [Related]
8. MeTA: a welcome force for access to medicines.
Lancet; 2008 May; 371(9626):1724. PubMed ID: 18502276
[No Abstract] [Full Text] [Related]
9. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals.
Correa CM
Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300
[No Abstract] [Full Text] [Related]
10. US changes trade policy on essential medicines.
Yamey G
BMJ; 1999 Dec; 319(7224):1521. PubMed ID: 10591704
[No Abstract] [Full Text] [Related]
11. From the World Health Organization. Essential medicines: 25 years of better health.
JAMA; 2002 Dec; 288(24):3102. PubMed ID: 12495381
[No Abstract] [Full Text] [Related]
12. How poor countries can gain access to cheap drugs.
Fleck F
BMJ; 2003 Sep; 327(7416):642. PubMed ID: 14500433
[No Abstract] [Full Text] [Related]
13. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
Sykes AO
Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
[No Abstract] [Full Text] [Related]
14. Drug donations to developing countries.
Khare AK
World Hosp Health Serv; 2001; 37(1):18-9, 33-4. PubMed ID: 11372253
[TBL] [Abstract][Full Text] [Related]
15. The concept of essential medicines: lessons for rich countries.
Hogerzeil HV
BMJ; 2004 Nov; 329(7475):1169-72. PubMed ID: 15539676
[TBL] [Abstract][Full Text] [Related]
16. No deal in sight on cheap drugs for poor countries.
Fleck F
BMJ; 2003 Mar; 326(7387):465. PubMed ID: 12609924
[No Abstract] [Full Text] [Related]
17. World's poorest countries can improve access to medicines through local production, says United Nations.
Zarocostas J
BMJ; 2011 May; 342():d3101. PubMed ID: 21593099
[No Abstract] [Full Text] [Related]
18. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
Cohen-Kohler JC; Forman L; Lipkus N
Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
[TBL] [Abstract][Full Text] [Related]
19. A prescription for drug delivery.
Affolder R; Rizzo I; Burgess C; Bchir A; Lob-Levyt J
Nature; 2007 Sep; 449(7159):170-2. PubMed ID: 17851513
[No Abstract] [Full Text] [Related]
20. Donation of medicines to developing countries.
Smego RA; Gebrian B
Clin Infect Dis; 1994 May; 18(5):847-8. PubMed ID: 8075299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
